| GA23246-1mg |
|
954420-51-0 |
Neuroendocrine Regulatory Peptide-1 (rat)
|
0 |
C110H180N32O38 |
|
|
|
| GA23246-005mg |
|
954420-51-0 |
Neuroendocrine Regulatory Peptide-1 (rat)
|
0 |
C110H180N32O38 |
|
|
|
| GA23245-250mg |
|
282726-22-1 |
|
0 |
C19H31N3O2 |
|
|
|
| GA23245-50mg |
|
282726-22-1 |
|
0 |
C19H31N3O2 |
|
|
|
| GA23244-50μg |
|
917528-37-1 |
|
0 |
C424H684N116O136 |
|
|
|
| GA23243-50μg |
|
917528-36-0 |
|
0 |
C424H683N117O137 |
|
|
|
| GA23242-250μg |
|
917528-35-9 |
|
0 |
C427H691N113O134 |
|
|
|
| GA23242-50μg |
|
917528-35-9 |
|
0 |
C427H691N113O134 |
|
|
|
| GA23241-1mg |
|
1872441-22-9 |
Nesfatin-1 (30-59) (mouse, rat)
|
0 |
C167H260N40O54 |
|
|
|
| GA23241-005mg |
|
1872441-22-9 |
Nesfatin-1 (30-59) (mouse, rat)
|
0 |
C167H260N40O54 |
|
|
|
| GA23240-1mg |
|
1872441-21-8 |
Nesfatin-1 (30-59) (human)
|
0 |
C167H263N41O54 |
|
|
|
| GA23240-005mg |
|
1872441-21-8 |
Nesfatin-1 (30-59) (human)
|
0 |
C167H263N41O54 |
|
|
|
| GA23239-25g |
|
5703-94-6 |
|
0 |
C18H38O5 |
|
|
|
| GA23239-5g |
|
5703-94-6 |
|
0 |
C18H38O5 |
|
|
|
| GA23238-25g |
|
23244-49-7 |
|
0 |
C20H42O6 |
|
|
|
| GA23238-5g |
|
23244-49-7 |
|
0 |
C20H42O6 |
|
|
|
| GA23237-250mg |
|
194351-53-6 |
N-2-Hydroxyethyl-Val-Leu-anilide
|
0 |
C19H31N3O3 |
|
|
|
| GA23237-50mg |
|
194351-53-6 |
N-2-Hydroxyethyl-Val-Leu-anilide
|
0 |
C19H31N3O3 |
|
|
|
| GA23236-250mg |
|
194351-51-4 |
N-2-Ethoxyethyl-Val-Ala-anilide
|
0 |
C18H29N3O3 |
|
|
|
| GA23236-50mg |
|
194351-51-4 |
N-2-Ethoxyethyl-Val-Ala-anilide
|
0 |
C18H29N3O3 |
|
|
|
